Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Ridker Paul M. and MacFadyen Jean G. and Thuren Tom and Everett Brendan M. and Libby Peter and Glynn Robert J. and CANTOS Trial Group and Forster Tamás and Ridker Paul and Lorenzatti Alberto and Krum Henry and Varigos John and Siostrzonek Peter and Sinnaeve Peter and Fonseca Francisco and et al.: Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
LANCET, 390 (10105). pp. 1833-1842. ISSN 0140-6736 (2017)

[thumbnail of Ridker.pdf]
Preview
Text
Ridker.pdf - Published Version

Download (356kB) | Preview
Creators:
Ridker Paul M.
MacFadyen Jean G.
Thuren Tom
Everett Brendan M.
Libby Peter
Glynn Robert J.
CANTOS Trial Group
Forster Tamás (kollab) MTMT
Ridker Paul (kollab)
Lorenzatti Alberto (kollab)
Krum Henry (kollab)
Varigos John (kollab)
Siostrzonek Peter (kollab)
Sinnaeve Peter (kollab)
Fonseca Francisco (kollab)
et al. (kollab)
Item Type: Journal Article
Szerzők száma: 113
Journal or Publication Title: LANCET
Date: 2017
Volume: 390
Number: 10105
Page Range: pp. 1833-1842
ISSN: 0140-6736
Faculty/Unit: Faculty of Medicine
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 31270601
DOI azonosító: https://doi.org/10.1016/S0140-6736(17)32247-X
Date Deposited: 2022. Apr. 12. 14:02
Last Modified: 2022. Aug. 11. 11:07
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/24062
Web of Science® Times Cited: 969 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year